GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Cyclically Adjusted Price-to-FCF

Alliance Pharma (LSE:APH) Cyclically Adjusted Price-to-FCF : 7.04 (As of May. 16, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Cyclically Adjusted Price-to-FCF?

As of today (2024-05-16), Alliance Pharma's current share price is £0.352. Alliance Pharma's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec22 was £0.05. Alliance Pharma's Cyclically Adjusted Price-to-FCF for today is 7.04.

The historical rank and industry rank for Alliance Pharma's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

LSE:APH' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 6.62   Med: 26.78   Max: 67.13
Current: 7.47

During the past 13 years, Alliance Pharma's highest Cyclically Adjusted Price-to-FCF was 67.13. The lowest was 6.62. And the median was 26.78.

LSE:APH's Cyclically Adjusted Price-to-FCF is ranked better than
92.66% of 327 companies
in the Drug Manufacturers industry
Industry Median: 33.34 vs LSE:APH: 7.47

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Alliance Pharma's adjusted free cash flow per share data of for the fiscal year that ended in Dec22 was £0.037. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is £0.05 for the trailing ten years ended in Dec22.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alliance Pharma Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Alliance Pharma's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Cyclically Adjusted Price-to-FCF Chart

Alliance Pharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.65 29.05 23.68 24.83 11.33

Alliance Pharma Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 24.83 - 11.33 -

Competitive Comparison of Alliance Pharma's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alliance Pharma's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's Cyclically Adjusted Price-to-FCF falls into.



Alliance Pharma Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Alliance Pharma's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=0.352/0.05
=7.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alliance Pharma's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec22 is calculated as:

For example, Alliance Pharma's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec22 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec22 (Change)*Current CPI (Dec22)
=0.037/125.3000*125.3000
=0.037

Current CPI (Dec22) = 125.3000.

Alliance Pharma Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 -0.002 99.200 -0.003
201412 0.032 99.900 0.040
201512 0.026 100.400 0.032
201612 0.033 102.200 0.040
201712 0.051 105.000 0.061
201812 0.038 107.100 0.044
201912 0.060 108.500 0.069
202012 0.069 109.400 0.079
202112 0.061 114.700 0.067
202212 0.037 125.300 0.037

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alliance Pharma  (LSE:APH) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Alliance Pharma Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Alliance Pharma (LSE:APH) Business Description

Traded in Other Exchanges
Address
Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).